因类风湿关节炎行初次连接式半限制型全肘关节置换术:单中心三十年461例肘关节经验
该单中心研究回顾了1982至2006年间因类风湿关节炎接受Coonrad-Morrey连接式半限制型全肘关节置换术的461例肘关节,中位随访10年。假体无翻修或取出的生存率10年为92%、15年为83%、20年为68%,作者认为临床结果满意且机械失败生存率合理。
要点
- 435例肘关节(94%)随访至少2年,中位随访10年,无翻修或取出生存率10年92%、15年83%、20年68%。
- 49例(11%)肘关节因深部感染(10例)或机械失败(39例)行组件翻修或取出。
- 存活假体中最常见影像学表现为衬套磨损(71例,23%),但仅2%因孤立性衬套磨损翻修。
核心结论
- 使用骨水泥固定的连接式半限制型全肘关节置换术治疗类风湿关节炎可获得满意的临床结果,20年无机械失败生存率合理。
- 尽管约四分之一的患者影像学可见衬套磨损,但因孤立性衬套磨损行翻修并不常见。
研究设计与样本
- 单中心回顾性研究,1982年至2006年间对387例类风湿关节炎患者共461例肘关节行初次Coonrad-Morrey全肘关节置换术。
- 其中55例肘关节同期治疗创伤或创伤后病变;女性305例(365例肘关节,79%),男性82例(96例肘关节,21%)。
- 10例患者(10例肘关节)失访,9例患者(10例肘关节)死亡,6例患者(6例肘关节)在术后2年内接受翻修手术。
- 435例肘关节(362例患者,94%)随访至少2年,中位随访10年(范围2至30年)。
主要发现
- 末次随访时,49例(11%)肘关节接受组件翻修或取出,其中深部感染10例,机械失败39例。
- 另有8例肘关节存在影像学松动证据。
- 存活假体且随访至少2年者,Mayo肘关节功能评分(MEPS)中位数为90分。
- 存活肘关节且影像学随访至少2年者中,71例(23%)发现衬套磨损,但仅2%因孤立性衬套磨损行翻修。
- 以任何原因翻修或取出为终点,假体生存率10年为92%(95%CI 88%至94%),15年为83%(95%CI 77%至88%),20年为68%(95%CI 56%至78%)。
关键数值与推荐
- 随访至少2年的存活假体,Mayo肘关节功能评分中位数为90分。
- 10年无任何原因翻修或取出生存率为92%(95%CI 88%至94%),15年为83%(95%CI 77%至88%),20年为68%(95%CI 56%至78%)。
- 20年以无菌性松动翻修为终点的生存率为88%(95%CI 83%至92%),以孤立性衬套更换为终点的生存率为89%(95%CI 77%至95%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elbow arthroplasty is the treatment of choice for end-stage rheumatoid arthritis (RA). The purpose of this study was to determine the long-term outcome of a linked semiconstrained elbow arthroplasty implant design in patients with RA. METHODS: Between 1982 and 2006, 461 primary total elbow arthroplasties using the Coonrad-Morrey prosthesis were performed in 387 patients with RA. Fifty-five of the arthroplasties were performed to treat concurrent traumatic or posttraumatic conditions. There were 305 women (365 elbows, 79%) and 82 men (96 elbows, 21%). Ten patients (10 elbows) were lost to follow-up, 9 patients (10 elbows) died, and 6 patients (6 elbows) underwent revision surgery within the first 2 years. For the 435 elbows (362 patients, 94%) with a minimum of 2 years of follow-up, the median follow-up was 10 years (range, 2 to 30 years). RESULTS: At the most recent follow-up, 49 (11%) of the elbows had undergone component revision or removal (deep infection, 10 elbows; and mechanical failure, 39 elbows). Eight additional elbows were considered to have radiographic evidence of loosening. For surviving implants followed for a minimum of 2 years, the median Mayo Elbow Performance Score (MEPS) was 90 points. Bushing wear was identified in 71 (23%) of the surviving elbows with a minimum of 2 years of radiographic follow-up; however, only 2% of the elbows had been revised for isolated bushing wear. The rate of survivorship free of implant revision or removal for any reason was 92% (95% confidence interval [CI] = 88% to 94%) at 10 years, 83% (95% CI = 77% to 88%) at 15 years, and 68% (95% CI = 56% to 78%) at 20 years. The survivorship at 20 years was 88% (95% CI = 83% to 92%) with revision due to aseptic loosening as the end point and 89% (95% CI = 77% to 95%) with isolated bushing exchange as the end point. Risk factors for implant revision for any cause included male sex, a history of concomitant traumatic pathology, and implantation of an ulnar component with a polymethylmethacrylate surface finish. CONCLUSIONS: Elbow arthroplasty using a cemented linked semiconstrained elbow arthroplasty provides satisfactory clinical results in the treatment of RA with a reasonable rate of survivorship free of mechanical failure at 20 years. Although bushing wear was identified on radiographs in approximately one-fourth of the patients, revision for isolated bushing wear was uncommon. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Sanchez-Sotelo J, Baghdadi YM, Morrey BF, et al. Primary Linked Semiconstrained Total Elbow Arthroplasty for Rheumatoid Arthritis: A Single-Institution Experience with 461 Elbows Over Three Decades. J Bone Joint Surg Am. 2016. PMID: 27869626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。